A new preclinical study from Scripps Research suggests that a drug already approved by the U.S. Food and Drug Administration ...

"He barely lifted his head off his bed and I knew something was really wrong," Kassidy Ciarrone told Newsweek.

Broader formulary coverage is associated with lower odds of multiple sclerosis (MS) relapse among Medicare beneficiaries, according to a study published online Aug. 1 in JAMA Network Open. Barbara ...

The research suggests common respiratory infections, such as the flu or COVID, are capable of stirring dormant cancer cells ...

Drug formulary restrictions in Medicare plans are linked to an increased risk for relapse in patients with multiple sclerosis ...

Early withdrawal of a treatment for patients with a rare kidney disease is possible without relapse, safer for patients and ...

Early withdrawal of a treatment for patients with a rare kidney disease is possible without relapse, safer for patients and ...

Professor Xun Lan from the School of Basic Medical Sciences at Tsinghua University and Director Hongxing Liu from Hebei Yanda ...

During a live event, Matthew Lunning, DO, and participants discussed the process of determining if patients with DLBCL should ...

A study found neurofilament light chain at high levels in the blood and CSF of MS patients, suggesting its potential as a ...

After stepping away from steroids to prioritize health and family, unexpected business stress pushed me back into old habits.

Relapse in the process of eating disorder recovery is common but often overlooked. Journalist Mallary Tenore Tarpley ...